Mackenzie Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Buy
82,726
+37,266
+82% +$882K ﹤0.01% 921
2025
Q4
$1.2M Sell
45,460
-10,917
-19% -$238K ﹤0.01% 1004
2025
Q3
$963K Buy
56,377
+35,022
+164% +$501K ﹤0.01% 1075
2025
Q2
$268K Buy
+21,355
New +$254K ﹤0.01% 1447

Other funds holding ZYME

Mackenzie Financial's ZYME Position: Q1 2026 in Review

Mackenzie Financial increased its Zymeworks (ZYME) stake by 82% in Q1 2026, buying an estimated $882K and bringing the position to 82,726 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #921.

Mackenzie Financial first reported a position in ZYME in Q2 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Mackenzie Financial held 82,726 shares of Zymeworks worth $2.07M as of Q1 2026.
  • Mackenzie Financial bought 37,266 Zymeworks shares in Q1 2026, an estimated $882K.
  • Zymeworks made up ﹤0.01% of Mackenzie Financial's portfolio in Q1 2026, its #921 holding.
  • Mackenzie Financial first reported a position in Zymeworks in Q2 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.